Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Arms / Cohorts
Observational:Newly diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Accepting patients
Observational:Newly diagnosed Higher-Risk Myelodysplastic Syndromes (HR-MDS)
Accepting patients
Observational:Newly diagnosed Acute Myeloid Leukemia (AML)
Accepting patients
Observational:Newly diagnosed Idiopathic cytopenia of undetermined significance (ICUS)
Accepting patients
Observational:Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Accepting patients
Observational:Luspatercept Treated Cohort (LTC)
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.